[1]
Leelo Al-Obaidy, A.K. , A. Kareem, H. and Jabbar Hasan, Y. 2025. Impact of Thyroid Hormone Receptor alpha Expression and PD-L1 on Progression-Free Survival of NSCLC Patients Treated with Pembrolizumab Immunotherapy. Journal of Neonatal Surgery. 14, 4S (Mar. 2025), 1217–1231. DOI:https://doi.org/10.52783/jns.v14.1937.